26. February 2018

A comparison of Hydroxypropyl and Sulfobutyl Betadex As a result of thorough development work, CycloLab Ltd (Budapest, Hungary) has established and validated the production of USP-complying Betadex Sulfobutyl Ether Sodium formulation excipient (SBECD, DexolveTM) in 2008. This cyclodextrin (CD) derivative is the main component of several commercial drug formulations worldwide acting as a solubility and stability enhancer. SBECD is one of the two parenterally applicable cyclodextrin derivatives...